Davidson Matt (CIK 1741937) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-16). Recent activity: Buy ADIL (61,647 shares), Buy ADIL (3,427 shares), Buy ADIL (232,417 shares), Buy ADIL (1,822 shares), Buy ADIL (101 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | Buy | 61,647 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | Buy | 3,427 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | Buy | 232,417 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | Buy | 1,822 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | Buy | 101 | $0 |
Source: SEC Form 4 filings · as of 2026-06-16